Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer

Proteomic alterations between Gleason 6 versus Gleason 9 were exclusive to the disease microenvironment, observed in both the tumor epithelium and tumor-involved stroma. Further, the molecular alterations measured in the tumor-involved stroma from Gleason 9 cases relative to the benign stroma have unique significance in disease aggressiveness, development, and/or progression. Our data provide supportive evidence of a need for further investigations into targeting stromal reservoirs of cholesterol and/or deoxynucleoside triphosphates in PCa tumors and further highlight the necessity for independent examination of the TME epithelial and stromal compartments.

Authors

Institutions

Publication Details

Journal
Clinical Proteomics
Published
2025-04-20
DOI
https://doi.org/10.1186/s12014-025-09534-8
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer

Nicholas W. Bateman, Tamara L. Lotan, Waleed Barakat, Jonathan D. Ogata et al.
1 citations
Clinical Proteomics
Prostate Cancer Treatment and Research
1.52
article

Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer

Nicholas W. Bateman, Tamara L. Lotan, Waleed Barakat, Jonathan D. Ogata, Allison L. Hunt, Tamara Abulez, Sasha C. Makohon‐Moore, Brian L. Hood, Thomas P. Conrads, Kenneth J. Pienta, Donald L. Trump, Katlin N. Wilson, Haresh Mani, Kelly A. Conrads
article en
1 citations

Abstract

Proteomic alterations between Gleason 6 versus Gleason 9 were exclusive to the disease microenvironment, observed in both the tumor epithelium and tumor-involved stroma. Further, the molecular alterations measured in the tumor-involved stroma from Gleason 9 cases relative to the benign stroma have unique significance in disease aggressiveness, development, and/or progression. Our data provide supportive evidence of a need for further investigations into targeting stromal reservoirs of cholesterol and/or deoxynucleoside triphosphates in PCa tumors and further highlight the necessity for independent examination of the TME epithelial and stromal compartments.

Clinical ProteomicsVol. 22(1)
Inova Health System (US), Henry M. Jackson Foundation (US), Johns Hopkins University (US), Uniformed Services University of the Health Sciences (US), Johns Hopkins Medicine (US), Walter Reed National Military Medical Center (US), Inova Fairfax Hospital (US), Sidney Kimmel Comprehensive Cancer Center (US)
Good health and well-being
Openalex Percentile: Top 20%
Prostate Cancer Treatment and Research
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer — Nicholas W. Bateman, Tamara L. Lotan, et al. · Clinical Proteomics (2025) | TGRS Research Map | TGRS